BioCentury
ARTICLE | Company News

Apex Bioscience, VitaResc deal

July 12, 1999 7:00 AM UTC

VitaResc, an intensive care medicine company, acquired Apex, into which VitaResc merged its U.S. subsidiary. Apex's pyridoxalated hemoglobin polyoxyethylene has completed Phase II testing to treat nit...